Advertisement
A live webcast of Bioniche's presentation can be accessed athttp://www.wsw.com/webcast/rrshq12/bnc.to. A replay of the presentation willbe archived for 90 days after the conference. For more information about theRodman & Renshaw 9th Annual Healthcare Conference, please visithttp://www.rodmanandrenshaw.com/conferences?id=6.
Advertisement
About Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc. is a research-based, technology-drivenCanadian biopharmaceutical company focused on the discovery, development,manufacturing, and marketing of proprietary products for human and animalhealth markets worldwide. The fully-integrated company employs approximately198 skilled personnel and has three operating divisions: Human Health, AnimalHealth, and Food Safety. The Company's primary goal is to develop proprietarycancer therapies supported by revenues from marketed products in human andanimal health. For more information, please visit www.Bioniche.com.
Except for historical information, this news release may containforward-looking statements that reflect the Company's current expectationregarding future events. These forward-looking statements involve risk anduncertainties, which may cause, but are not limited to, changing marketconditions, the successful and timely completion of clinical studies, theestablishment of corporate alliances, the impact of competitive products andpricing, new product development, uncertainties related to the regulatoryapproval process, and other risks detailed from time to time in the Company'songoing quarterly and annual reporting.
SOURCE Bioniche Life Sciences Inc.
